Growth factor signaling predicts therapy resistance mechanisms and defines neuroblastoma subtypes
Sign Up to like & getrecommendations! Published in 2021 at "Oncogene"
DOI: 10.1038/s41388-021-02018-7
Abstract: Neuroblastoma (NB) has a low frequency of recurrent mutations compared to other cancers, which hinders the development of targeted therapies and novel risk stratification strategies. Multikinase inhibitors have shown potential in treating high-risk NB, but… read more here.
Keywords: epo ngf; growth factor; factor signaling; growth ... See more keywords